bf/NASDAQ:NAUT_icon.jpeg

NASDAQ:NAUT

Nautilus Biotechnology, Inc.

  • Stock

USD

Last Close

2.88

26/07 20:00

Market Cap

284.35M

Beta: 0.81

Volume Today

55.14K

Avg: 103.59K

PE Ratio

−5.53

PFCF: −8.75

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
53.62K
-
288.62K
438.25%
1.10M
279.91%
1.50M
36.57%
1.46M
2.80%
average receivables
book value per share
0.35
-
0.35
0.00%
-0.24
168.88%
4.30
1,896.55%
2.53
41.28%
0.00
99.92%
capex per share
-0.01
-
-0.03
261.81%
-0.02
30.56%
-0.00
99.90%
capex to depreciation
-0.39
-
-0.80
103.37%
-0.68
14.79%
-0.43
37.08%
capex to operating cash flow
0.07
-
0.06
12.13%
0.05
12.26%
0.05
6.92%
capex to revenue
cash per share
10.05K
-
10.28K
2.32%
0.62
99.99%
4.09
561.62%
1.48
63.83%
0.00
99.91%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.03
-
1.85
5,290.73%
0.06
96.96%
0.08
34.19%
0.09
14.95%
0.11
30.80%
debt to equity
1.00
-
55.00
5,400.00%
-0.16
100.29%
0.08
151.41%
0.10
16.59%
0.13
35.51%
dividend yield
earnings yield
4.18
-
0.02
99.59%
-0.01
167.54%
-0.11
890.95%
-0.28
147.15%
-0.00
99.94%
enterprise value
153.88M
-
424.20M
175.68%
1.31B
209.77%
281.94M
78.54%
140.07M
50.32%
373.52B
266,576.38%
enterprise value over ebitda
0.25
-
164.51
66,888.65%
-98.08
159.62%
-5.92
93.97%
-2.33
60.67%
-5.87K
252,031.16%
ev to operating cash flow
-0.65
-
-1.31K
202,668.60%
-93.89
92.83%
-7.18
92.35%
-3.06
57.44%
-7.22K
236,123.98%
ev to sales
free cash flow per share
-16.58
-
-0.02
99.86%
-0.12
433.57%
-0.49
308.68%
-0.39
21.39%
-0.00
99.89%
free cash flow yield
-1.59
-
-0.00
99.86%
-0.01
413.41%
-0.09
756.01%
-0.21
126.21%
-0.00
99.93%
graham net net
10.04K
-
10.27K
2.32%
-0.31
100.00%
3.68
1,301.70%
1.20
67.43%
0.00
99.91%
graham number
18.47
-
1.18
93.58%
0.82
30.46%
7.60
821.93%
5.39
28.98%
0.00
99.91%
income quality
-0.38
-
-0.13
66.96%
0.90
813.21%
0.78
12.97%
0.79
1.40%
0.81
2.70%
intangibles to total assets
0
-
0
0
0
0
0
interest coverage
-10.94
-
interest debt per share
0.35
-
19.13
5,400.00%
0.04
99.80%
0.36
823.67%
0.29
18.41%
0.00
99.90%
inventory turnover
invested capital
1.00
-
55.00
5,400.00%
-0.16
100.29%
0.08
151.41%
0.10
16.59%
0.13
35.51%
market cap
150.07M
-
150.07M
0%
1.35B
796.81%
437.52M
67.49%
224.26M
48.74%
373.51B
166,450.54%
net current asset value
-139.49M
-
-142.84M
2.40%
-37.07M
74.05%
314.35M
947.92%
152.08M
51.62%
136.63M
10.16%
net debt to ebitda
0.01
-
106.31
1,752,066.05%
2.38
97.77%
3.26
37.41%
1.40
57.16%
-0.24
117.10%
net income per share
43.59
-
0.18
99.59%
-0.13
170.19%
-0.60
373.10%
-0.51
14.12%
-0.00
99.90%
operating cash flow per share
-16.58
-
-0.02
99.86%
-0.11
400.63%
-0.46
311.76%
-0.37
20.86%
-0.00
99.89%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
4.30
-
0.02
99.60%
-0.18
1,160.05%
-0.13
31.27%
-0.18
44.20%
-0.21
14.44%
revenue per share
roe
125.32
-
0.52
99.59%
0.53
1.90%
-0.14
126.33%
-0.20
46.25%
-0.24
18.56%
roic
-11.17
-
-0.00
99.98%
0.78
28,313.97%
-0.12
115.27%
-0.19
56.37%
-0.19
2.09%
sales general and administrative to revenue
shareholders equity per share
0.35
-
0.35
0.00%
-0.24
168.88%
4.30
1,896.55%
2.53
41.28%
0.00
99.92%
stock based compensation to revenue
tangible asset value
5.00M
-
5.00M
0.00%
-29.72M
694.42%
363.58M
1,323.30%
314.92M
13.38%
265.35M
15.74%
tangible book value per share
0.35
-
0.35
0.00%
-0.24
168.88%
4.30
1,896.55%
2.53
41.28%
0.00
99.92%
working capital
1.33M
-
552.66K
58.36%
74.64M
13,405.65%
343.41M
360.08%
180.42M
47.46%
167.72M
7.04%

All numbers in USD (except ratios and percentages)